Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage - Nature Communications

Australia News News

Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage - Nature Communications
Australia Latest News,Australia Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 37 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 18%
  • Publisher: 51%

Inhalation drug may prevent severe pneumonia TU_Muenchen NatureComms

. In brief, macrophage-specific miR-21–deficient mice were generated by crossing miR-21–floxed mice withpromotor that is specifically active in macrophages. All mice were bred in C57BL/6N genetic background. All animal studies were performed in accordance with relevant guidelines and regulations of the responsible authorities and approval was obtained from the IRB at the Regierung von Oberbayern . Mice were housed in rooms maintained at constant temperature and humidity with a 12 h light cycle.

The forced oscillation perturbation Prime-8 was performed. This volume-driven, 8 s long measurement subjects the lung to a standardized test signal of oscillatory frequencies well above and below the subject´s ventilation frequency. Different frequencies will probe different regions of the lung. The measurements were fitted to constant phase model to obtain Newtonian resistance , tissue damping and tissue elastance .

Immune cell-enriched fractions from the lung were either stained with antibodies against CD45-FITC , F4/80-PECy7 , CD11b-PE and CD24-PE/Dazzle 594 to isolate macrophages, or with antibodies against CD45-FITC , Ly6G-PE/Dazzle 594 , CD3-PECy7 and CD19-PECy5 to isolate neutrophils and T cells.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Australia Latest News, Australia Headlines



Render Time: 2025-03-03 00:28:19